Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AC
- Chemical substanceL04AC07Tocilizumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 15 registrations
- Actemra80 MG / 4 ML · Solution · Hoffmann-LA Roche Limited
- Actemra162 MG / 0.9 ML · Solution · Hoffmann-LA Roche Limited
- Actemra400 MG / 20 ML · Solution · Hoffmann-LA Roche Limited
- Actemra200 MG / 10 ML · Solution · Hoffmann-LA Roche Limited
Spain
AEMPS · 14 registrations
At a glance
- ATC code
- L04AC07
- Registers
- 10
- Historical lists
- 2
- Registrations
- 80
- With their own page
- 74
- Companies
- 21
All medicines with Tocilizumab
Human medicines from every register that match Tocilizumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
80 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tocilizumab STADA (previously Tofidence) | European Union | Authorised | STADA Arzneimittel AG | ||
| Tocilizumab Stada 20 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 20 mg/ml | concentrado para solución para perfusión | Authorised | Stada Arzneimittel Ag |
| Tocilizumab STADA 20 mg/ml concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Stada Arzneimittel AG | |
| Tofidence | United States | 200MG/10ML, 400MG/20ML, 80MG/4ML | injectable | Marketed | Biogen Ma |
| Actemra | United States | 200MG/10ML, 400MG/20ML, 80MG/4ML | injectable | Marketed | Genentech |
| Actemra | United States | 162MG/0.9ML | injectable | Marketed | Genentech |
| Avtozma | United States | 162MG/0.9ML, 162MG/20ML | injectable | Marketed | Celltrion INC |
| Avtozma | United States | 200MG/10ML, 400MG/20ML, 80MG/4ML | injectable | Marketed | Celltrion INC |
| Tyenne | United States | 162MG/0.9ML | injectable | Marketed | Fresenius Kabi USA |
| Tyenne | United States | 80MG/4ML | Injection | Marketed | Fresenius Kabi USA, LLC |
| Tyenne | United States | 162MG/0.9ML | Injection | Marketed | Fresenius Kabi USA, LLC |
| Tyenne | United States | 200MG/10ML, 400MG/20ML, 80MG/4ML | injectable | Marketed | Fresenius Kabi USA |
| Tyenne | United States | 162MG/0.9ML | Injection | Marketed | Fresenius Kabi USA, LLC |
| Actemra | United States | 162MG/0.9ML | Injection | Marketed | Genentech, Inc. |
| Avtozma | United States | 200MG/10ML, 400MG/20ML, 80MG/4ML | injectable | Marketed | Celltrion INC |
| Tuyory | European Union | Authorised | Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.) | ||
| Tyenne | European Union | Authorised | Fresenius Kabi Deutschland GmbH | ||
| Tyenne 162 MG Solucion Inyectable en Pluma Precargada | Spain | 162 mg | solución inyectable en pluma precargada | Marketed | Fresenius Kabi Deutschland Gmbh |
| Tyenne 20 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 20 mg | concentrado para solución para perfusión | Marketed | Fresenius Kabi Deutschland Gmbh |
| Avtozma 162 MG Solucion Inyectable en Pluma Precargada | Spain | 162 mg | solución inyectable en pluma precargada | Marketed | Celltrion Healthcare Hungary Kft. |
| Roactemra 162 MG Solucion Inyectable en Pluma Precargada | Spain | 162 mg | solución inyectable en pluma precargada | Marketed | Roche Registration Gmbh |
| Tyenne 162 MG Solucion Inyectable en Jeringa Precargada | Spain | 162 mg | solución inyectable en jeringa precargada | Marketed | Fresenius Kabi Deutschland Gmbh |
| Avtozma | European Union | Authorised | Celltrion Healthcare Hungary Kft. | ||
| Avtozma 162 MG Solucion Inyectable en Jeringa Precargada | Spain | 162 mg | solución inyectable en jeringa precargada | Marketed | Celltrion Healthcare Hungary Kft. |
| Avtozma 20 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 20 mg/ml | concentrado para solución para perfusión | Marketed | Celltrion Healthcare Hungary Kft. |